On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|9|981-997

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.9, 2009-11, pp. : 981-997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 285-300

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

By L.P.L. Gilissen  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 479-486

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Drug Monitoring of Antidepressants: Cost Implications and Relevance to Clinical Practice

By Burke M.J.   Preskorn S.H.  

Clinical Pharmacokinetics, Vol. 37, Iss. 2, 1999-08 ,pp. : 147-165

Adis International

Access to resources Recommend Favorite

Thiopurines for Inflammatory Bowel Disease: Role of Pharmacogenetics

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 3, 2005-09 ,pp. : 213-215

John Wiley & Sons Inc

Access to resources Recommend Favorite